Soumitra Sahana1*, Sk Abdur Rahamat1, Indranil Chatterjee2, Rajeswar Das2, Suman Kumar Nath2, Snehansu Biswas2 and Sanchari Chatterjee2
1B. Pharm, Birbhum Pharmacy School, Birbhum, West Bengal, India
2Assistant Professor, Birbhum Pharmacy School, Birbhum, West Bengal, India
*Corresponding Author: Soumitra Sahana, B. Pharm, Birbhum Pharmacy School, Birbhum, West Bengal, India.
Received: September 01, 2020; Published: December 09, 2020
Hantaviruses are rodent viruses that have been realize as etiologic dealers of two illnesses of humans: HFRS (hemorrhagic fever with renal syndrome) and hantavirus pulmonary syndrome (HPS). This article gives a concise overview of hantavirus biology, the scientific aspects of HFRS and HPS, and checks for the detection of hantavirus infections in humans. Together, these viruses have yearly precipitated about 200,000 human infections global in current years, with a case fatality fee of 5 - 15% for HFRS and up to 40% for hantavirus cardiopulmonary syndrome (HCPS). The high fee of mortality ought to be decreased if advantageous therapeutics ought to be observed for cure of this illness. There is presently no wonderful remedy reachable for both HFRS or HCPS. In this paper, we summarized the Virology, Epidemiology of HFRS and HCPS, Diagnosis, and Treatment of hantaviruses disease.
Keywords: Hantavirus; Hemorrhagic Fever with Renal Syndrome (HFRS); Hantavirus Pulmonary Syndrome (HPS); Hantavirus Cardiopulmonary Syndrome (HCPS); Virology; Epidemiology; Diagnosis; Treatment
Citation: Soumitra Sahana., et al. “Diagnosis, Virology and Treatment for Hantavirus Pulmonary Syndrome (HPS): A Challenging Sickness to Human Health". Acta Scientific Microbiology 4.1 (2021): 52-59.
Copyright: © 2021 Soumitra Sahana., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.